A detailed history of Sunpointe, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sunpointe, LLC holds 3,388 shares of ABBV stock, worth $594,865. This represents 0.55% of its overall portfolio holdings.

Number of Shares
3,388
Previous 2,947 14.96%
Holding current value
$594,865
Previous $505 Million 32.36%
% of portfolio
0.55%
Previous 0.33%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$163.84 - $199.33 $72,253 - $87,904
441 Added 14.96%
3,388 $669 Million
Q2 2024

Jul 19, 2024

SELL
$154.79 - $180.76 $29,719 - $34,705
-192 Reduced 6.12%
2,947 $505 Million
Q1 2024

Apr 15, 2024

SELL
$159.82 - $182.1 $100,366 - $114,358
-628 Reduced 16.67%
3,139 $572 Million
Q4 2023

Feb 20, 2024

BUY
$137.6 - $154.97 $518,339 - $583,771
3,767 New
3,767 $584 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sunpointe, LLC Portfolio

Follow Sunpointe, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunpointe, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sunpointe, LLC with notifications on news.